Principal Financial Group’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Principal Financial Group’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-26,504	Closed	-$30K	–	2685
2022 Q1	$30K	Buy	26,504 +1,487	+6%	+$1.78K	﹤0.01%	2509
2021 Q4	$56K	Sell	25,017 -10,689	-30%	-$26.8K	﹤0.01%	2476
2021 Q3	$122K	Buy	35,706 +1,642	+5%	+$5.06K	﹤0.01%	2482
2021 Q2	$102K	Buy	+34,064	New	+$108K	﹤0.01%	2532
2015 Q3	–	Sell	-13,465	Closed	-$147K	–	2229
2015 Q2	$147K	Buy	+13,465	New	+$173K	﹤0.01%	2088
2014 Q3	–	Sell	-15,861	Closed	-$202K	–	2249
2014 Q2	$202K	Buy	+15,861	New	+$165K	﹤0.01%	2088
2013 Q4	–	Sell	-13,305	Closed	-$232K	–	2316
2013 Q3	$232K	Sell	13,305 -2,595	-16%	-$49.7K	﹤0.01%	2057
2013 Q2	$258K	Buy	+15,900	New	+$492K	﹤0.01%	1990

Other funds holding INFI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Principal Financial Group's INFI Position: Q2 2022 in Review

Principal Financial Group sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2022, closing a stake of 26,504 shares — an estimated $30K sold.

Principal Financial Group first reported a position in INFI in Q2 2013 and held it in 8 quarters. The position peaked at $258K in Q2 2013. 77 funds tracked by Wall St. Rank hold INFI as of Q2 2022.

Principal Financial Group reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2022 after selling out during the quarter.
Principal Financial Group sold 26,504 Infinity Pharmaceuticals, Inc. shares in Q2 2022, an estimated $30K.
Principal Financial Group first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 8 quarters.
Principal Financial Group's Infinity Pharmaceuticals, Inc. position peaked at $258K in Q2 2013.
77 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2022.

Based on Principal Financial Group's 13F filing for Q2 2022, filed 10 Aug 2022.